| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/08/2004 | US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease |
| 07/08/2004 | US20040132739 e.g. RO 28-2653 in combination with Cisplatin, Paclitaxel, Gemcitabine or Etoposide; treating patients with solid metastasized or non-metastasized tumors |
| 07/08/2004 | US20040132737 especially dimethylphenylpiperazinium; treating a variety of pulmonary diseases with fewer side effects than other anti-inflammatory drugs, such as steroids |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132727 Quinoline and quinazoline derivatives and drugs containing the same |
| 07/08/2004 | US20040132725 tyrphostin preparations enriched in certain geometric isomers; treating protein tyrosine kinase related disorders. especially with slow release formulations |
| 07/08/2004 | US20040132724 e.g., cis-1-Acetyl-6-ethyl-N-(4-ethylphenyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinamine; atopic dermatitis, urticaria, various allergies bullous pemphigoid, industrial sensitization, chronic transplant rejection and COPD |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132689 Aqueous preparation containing a shark-derived chondroitin iron sulfate colloid |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132669 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 07/08/2004 | US20040132648 Remedies and/or preventives for conformational diseases |
| 07/08/2004 | US20040132618 Therapeutic amides |
| 07/08/2004 | US20040132179 Treatment of t cell disorders |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132159 Novel beta-secretase and modulation of beta-secretase activity |
| 07/08/2004 | US20040132140 comprises using a cell resistant to a lectin which recognizes a sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in the reducing end through alpha -bond in a complex N-glycoside-linked sugar chain |
| 07/08/2004 | US20040132053 Sphingosine kinase enzyme |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131702 Mixture with acid |
| 07/08/2004 | US20040131692 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 07/08/2004 | US20040131616 Methods of inhibiting proliferative diseases |
| 07/08/2004 | US20040131611 Antitumor agents, anticancer agents; synergistic mixture |
| 07/08/2004 | US20040131608 Antibodies; suppression, therapy, prevention |
| 07/08/2004 | US20040131602 Methods for enhancing graft survival by modulating heme oxygenase activity |
| 07/08/2004 | US20040131588 Formulation having mobilising activity |
| 07/08/2004 | US20040131587 Administering mixture of dendritic cells, apoptosis or necrosis agents,chemattractants |
| 07/08/2004 | US20040131585 Identification and use og human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 07/08/2004 | US20040131583 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/08/2004 | US20040131545 Anticholesterol agents |
| 07/07/2004 | EP1435387A1 The oncolytic microorganisms expressing hsp and uses thereof |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1435244A1 Drugs ameliorating hypo-hdl cholesterolemia |
| 07/07/2004 | EP1435236A1 Malignant cell differentiation inducer compositions and utilization of the same |
| 07/07/2004 | EP1435235A1 Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 07/07/2004 | EP1435234A1 Compositions for lessening oxidative stress |
| 07/07/2004 | EP1434990A2 Method for identifying compounds the specifically deplete mast cells |
| 07/07/2004 | EP1434886A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 07/07/2004 | EP1434885A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 07/07/2004 | EP1434865A2 Variants and exons of the glyt1 transporter |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434802A1 Human tissue factor antibodies |
| 07/07/2004 | EP1434792A2 Peptidyl ketones as inhibitors of dpiv |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434782A2 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
| 07/07/2004 | EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434774A1 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 07/07/2004 | EP1434772A1 Compounds and methods |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434766A1 Piperidine compounds as muscarinic antagonists |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434762A1 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/07/2004 | EP1434756A1 Novel compounds |
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434603A2 Method of treatment using ligand-immunogen conjugates |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434587A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | EP1434584A2 Compositions and methods of treatment of cancer |
| 07/07/2004 | EP1434581A1 3- hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434578A1 Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands |
| 07/07/2004 | EP1434575A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 07/07/2004 | EP1401431A4 Human growth hormone antagonists |
| 07/07/2004 | EP1377280A4 Bulking agents as satiety agents |
| 07/07/2004 | EP1235827B1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1222251A4 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 07/07/2004 | EP1073435B1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 07/07/2004 | EP1073431B1 Use of nmda antagonists for treatment of irritable bowel syndrome |
| 07/07/2004 | EP1047694B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/07/2004 | EP0981520B1 Efficient enantioselective addition reaction using an organozinc reagent |
| 07/07/2004 | EP0946552B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/07/2004 | EP0907373B1 Use of synergistic compositions of il-12 and ifn-alpha for the treatment of infectious diseases |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511154A Quinuclidines-substituted-multi-cycli-heteroaryls for treatment of disease |
| 07/07/2004 | CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511044A Elogated and multiple spacers in activatible prodrugs |
| 07/07/2004 | CN1511043A Pregabalin lactose conjugates |
| 07/07/2004 | CN1511038A Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 07/07/2004 | CN1511036A Combination comprising signal transduction inhibitor and epothilone derivative |
| 07/07/2004 | CN1511017A Treating epidermlyosis bullosa with thymosin Beta-4 |
| 07/07/2004 | CN1510034A Indazole compound, preparing method thereof and medicine composition containing the same |
| 07/07/2004 | CN1509737A Chinese medicinal composition with delaying senility and improving sleep functions, and preparing method thereof |
| 07/07/2004 | CN1509724A Propolis and preparing method thereof |
| 07/07/2004 | CN1156569C Artificial culture method of north cordyceps cporophores and its living product |
| 07/07/2004 | CN1156492C Somatostatin peptides |